Modulation of human platelet adenylate cyclase by prostacyclin (PGX)
Authors:
- R.R. GormanRGR.R. Gorman
- S. BuntingSBS. Bunting
- O.V. MillerOMO.V. Miller
- 1 March 1977
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 13 (3) , 377-388
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The chemical structure of prostaglandin X (prostacyclin)Prostaglandins, 1976
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Thromboxanes: Selective Biosynthesis and Distinct Biological PropertiesScience, 1976
- Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxidesNature, 1976
- Flurbiprofen, a new potent inhibitor of platelet aggregationThrombosis Research, 1973
- Cyclic 3′,5′-adenosine monophosphate in human blood plateletsJournal of Clinical Investigation, 1971
- Divergent effects of epinephrine and prostaglandin E1 on the level of cyclic AMP in human blood plateletsPharmacological Research Communications, 1969
- Glucagon-Sensitive Adenyl Cyclase in Plasma Membrane of Hepatic Parenchymal CellsScience, 1969